Long Alison S 4
4 · Taysha Gene Therapies, Inc. · Filed May 31, 2024
Insider Transaction Report
Form 4
Long Alison S
Director
Transactions
- Award
Common Stock
2024-05-29+49,220→ 49,220 total - Award
Stock Option (right to buy)
2024-05-29+98,440→ 98,440 totalExercise: $3.17Exp: 2034-05-29→ Common Stock (98,440 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.